Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$827
|
$777B |
13.3x |
31.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$191
|
$492B |
5.3x |
14.2x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$226
|
$464B |
7.8x |
17.7x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 286
|
$309B |
4.0x |
10.1x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£127
|
$289B |
5.0x |
14.4x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 104
|
$276B |
5.0x |
12.2x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$84
|
$237B |
3.7x |
8.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$297
|
$208B |
5.9x |
11.4x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$186B |
2.9x |
7.5x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$118
|
$167B |
5.8x |
11.2x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$44
|
$126B |
2.7x |
8.0x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£16
|
$106B |
2.5x |
7.4x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$408
|
$99.7B |
8.5x |
22.4x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4198
|
$70.3B |
2.4x |
8.9x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7025
|
$69.1B |
8.6x |
16.9x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€27
|
$68.8B |
1.3x |
6.2x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$142
|
$68.3B |
7.2x |
16.6x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€115
|
$67.1B |
2.7x |
9.6x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$470
|
$60.1B |
18.4x |
123.3x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 67
|
$57.1B |
12.5x |
42.3x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$576
|
$56.3B |
4.0x |
11.7x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£3
|
$51.2B |
3.5x |
13.8x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4035
|
$46.5B |
3.6x |
16.8x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€687
|
$45.1B |
12.3x |
54.8x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€49
|
$44.9B |
1.7x |
10.4x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 141
|
$43.6B |
8.7x |
38.2x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1655
|
$42.1B |
6.8x |
23.9x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 66
|
$38.2B |
2.2x |
7.7x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 197
|
$34.5B |
7.0x |
150.7x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$164
|
$33.3B |
74.2x |
-33.3x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 49
|
$30.4B |
2.7x |
13.0x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 8005
|
$26.3B |
1.7x |
7.1x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.6B |
1.8x |
6.1x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$144
|
$24.9B |
2.6x |
7.7x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 35
|
$23.1B |
11.7x |
31.4x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1586
|
$22.8B |
1.8x |
8.4x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 340
|
$19.7B |
48.5x |
321.8x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6573
|
$19.3B |
17.0x |
52.8x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 86
|
$17.9B |
11.0x |
112.8x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€11
|
$17.9B |
2.1x |
8.5x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2076
|
$17.0B |
4.8x |
12.7x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$16.5B |
N/A |
-45.7x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 195
|
$16.4B |
10.7x |
32.4x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$432
|
$16.4B |
5.2x |
9.9x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$16.2B |
3.6x |
13.7x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$88
|
$14.8B |
3.1x |
12.6x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$14.7B |
4.9x |
13.1x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 122
|
$14.1B |
31.9x |
-3105.0x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$13.9B |
3.0x |
15.8x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3533
|
$13.8B |
9.9x |
30.2x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 469
|
$13.4B |
49.4x |
-315.6x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 27
|
$13.2B |
2.3x |
13.1x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$138
|
$13.1B |
4.9x |
21.1x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1558
|
$13.0B |
4.1x |
16.2x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€180
|
$13.0B |
N/A |
N/A |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2446
|
$12.1B |
7.9x |
31.1x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$12.1B |
3.0x |
11.0x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$12.0B |
2.9x |
11.6x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 295
|
$11.9B |
4.1x |
11.2x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$57
|
$11.9B |
28.5x |
-24.9x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.3x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1233
|
$11.4B |
3.0x |
11.8x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$10.8B |
1.7x |
5.5x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$10.7B |
12.8x |
-26.3x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 977
|
$10.6B |
3.9x |
13.6x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1941
|
$10.3B |
3.8x |
15.5x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€114
|
$10.2B |
2.4x |
6.7x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$40
|
$10.2B |
4.4x |
12.3x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2418
|
$9.9B |
3.2x |
8.1x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 41
|
$9.7B |
1.6x |
12.3x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$53
|
$9.4B |
3.0x |
10.9x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$19
|
$9.3B |
N/A |
N/A |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$104
|
$9.2B |
3.5x |
-6.3x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$433
|
$9.0B |
12.3x |
-29.1x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$66
|
$8.7B |
6.9x |
10.6x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 44
|
$8.4B |
N/A |
N/A |
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 55
|
$8.4B |
13.7x |
46.1x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4505
|
$8.0B |
1.5x |
12.3x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$77
|
$7.8B |
9.5x |
N/A |
Caliway Biopharmaceuticals
|
Taiwan |
Drug Development & Therapeutics
|
TWD 160
|
$7.8B |
6902.6x |
-236.7x |
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$7.5B |
107.3x |
-12.6x |
Kelun
|
China |
Drug Development & Therapeutics,
Medical Supplies
|
CNY 35
|
$7.5B |
2.7x |
12.0x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1109
|
$7.3B |
2.0x |
9.6x |
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$7.3B |
1474.7x |
-7.3x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5567
|
$7.2B |
4.7x |
23.7x |
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$17
|
$7.2B |
297.6x |
-6.8x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$109
|
$7.1B |
40.6x |
-36.7x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 127
|
$6.7B |
3.5x |
13.6x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£18
|
$6.6B |
2.0x |
7.7x |
Merus
|
United States of America |
Drug Development & Therapeutics
|
$95
|
$6.5B |
133.4x |
-19.4x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$28
|
$6.4B |
3.0x |
-1.7x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$129
|
$6.4B |
11.2x |
-38.5x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 29
|
$6.3B |
1.5x |
7.9x |
Sumitomo Pharma
|
Japan |
Drug Development & Therapeutics
|
JPY 1734
|
$6.3B |
2.4x |
10.6x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2282
|
$6.3B |
2.0x |
8.8x |
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$50
|
$6.2B |
626.1x |
-10.7x |
Shanghai Allist
|
China |
Drug Development & Therapeutics
|
CNY 106
|
$6.2B |
9.3x |
27.8x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$21
|
$6.1B |
1.4x |
8.1x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 117010
|
$6.1B |
4.0x |
52.3x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1893
|
$6.1B |
3.8x |
20.1x |